The past days have been marked by landmark rulings from the Russian Supreme and Constitutional Courts, decisions that will influence future case law and the pharmaceutical market as a whole.
On February 17, 2026, the annual flagship seminar of Lidings, "Predictions 2026: Crystal Clarity Instead of Legal Fog," was held at the Hotel Metropol.
The event marked the beginning of a series of celebrations dedicated to the firm's 20th anniversary and brought together over 70 representatives from 50 Russian and international companies.
Lidings' lawyers together with invited speakers from the corporate sector discussed key legislative changes and shared current trends and practical tools.
2026 is a special year for our team — it marks our 20th anniversary. And we are especially pleased to kick it off with a seminar where we will look into the "Crystal of Predictions": back to the past — to review the key legal developments of the past year, and forward to the future — to share crystal-clear insights on the key business trends awaiting in 2026.
On 24 November 2025, the Delhi High Court issued a judgment in a major patent dispute Medilabo Rfp Inc. v. The Controller of Patents C.A. (Comm.Ipd-Pat) 16/2024, concerning the patent eligibility of a drug for neurodegenerative diseases.
In June 2024, the pharmaceutical industry faced a new practice by the Federal Antimonopoly Service (FAS), which began to consistently recognize the introduction of generic drugs onto the market as unfair competition.
On 4 December 2025 the results of the annual Pravo-300 law firms’ ranking were announced at an awarding ceremony at The Carlton Hotel in Moscow. This year Lidings expertise is highly praised in 17 key practice areas.
The new review of the most notable patents disputes in Life Sciences in Russia and CIS.
Partner and Head of the Lidings’ Intellectual Property practice Boris Malakhov will take part in an annual conference entitled Intellectual Property - 2025 organized by Pravo.ru. The conference will take place on 21 November 2025 in Baltschug Kempinski.
On August 7, 2025, a draft law “On Amending the Federal Law ‘On Protection of Competition’” (hereinafter, the “Draft Law”) was published. Prepared by the Federal Antimonopoly Service (hereinafter, the “FAS”), it aims to significantly narrow the scope of antitrust immunities concerning the results of intellectual activity.
On 7 July 2025, Federal Law No. 214-FL «On Amendments to Part Four of the Civil Code of the Russian Federation» was published. This law introduces the following significant changes to the provisions on the recovery of compensation for infringement of exclusive rights to intellectual property and means of individualisation equivalent thereto.
The site uses cookie technology to ensure optimal performance, analyze usage and improve user experience. By continuing to use the site, you consent to the placement of cookies on your device on the terms set out in the Privacy Policy.
To ensure optimal performance, analyze usage and improve user experience, the website may use web analytics systems (including Yandex.Metrica), which may place cookies on your device.
By continuing to use the website, you agree to the use of these technologies and the placement of cookies. You can delete cookies from your device through your browser settings and you can block the placement of cookies, however, in doing so, some website features may not be available due to the engine's technological limitations.
You can find more information in the Privacy Policy.